VEGFA and breast cancer: The primary endpoint of the present study was to investigate whether administration of an LH-RH analogue, followed by chemotherapy, radiation therapy and hormonal therapy (in ER+ patients) would reduce VEGF and T-Reg levels in premenopausal patients with high-risk early BC.